Global Spinal Cord Stimulators Market Size, Share, Research, Analysis and Foreca

Posted by OMR Global on February 11th, 2020

Spinal cord Stimulators market is expected to grow at a CAGR of 10.7% during the forecast period. A spinal Cord stimulator is a small device that aids in managing the chronic pain in a better way and to reduce the use of opioid medications. SCS may be used as an option for the people suffering from chronic back, leg or arm pain and when optimum results are not received with other therapies such as medication. It is surgically placed under the skin that transfers mild electric current to the spinal Cord. Pulse generator sends current to nerve fibers of the spinal Cord by thin wires. After turning on, the SCS stimulates the nerves in the area of pain and reduces the pain as the electrical pulses modify and stop the pain signal from reaching to the brain.  

To know more information, please request a free report sample 

The stimulator does not eradicate the source of pain; however, it interferes with the signal to the brain. Due to this, the relief from pain varies from patient to patient. Sometimes patients feel a tingling sensation, which is unpleasant; as a result of this, trial stimulation is performed before the permanent implantation. 50-70% reduction in pain can be achieved by the implantation. 

A full report of Global Spinal Cord Stimulators Market available at: 

In January 2018, Nevro Corporation received the US FDA approval for its next-generation Senza II SCS System delivering HF10 therapy. It provides better results of HF10 therapy by a smaller and more refined footprint compared to its conventional products. In June 2019, Nuvectra Corporation filed for expanded the US FDA approval of its Algovita SCS device. The company needs approval for full-body MR-conditional for the Algovita SCS. The device has already received the US FDA premarket approval in 2015. The US FDA has classified most of the neurostimulators into class II, and class III products.  

Global Spinal Cord Stimulators Market – Segmentation 

By Application 

  • Failed Back Syndrome
  • Complex Regional Pain Syndrome
  • Degenerative Disk Disease
  • Others 

By End-Users 

  • Hospitals and Clinics
  • Research Institutes 

Regional Analysis 

North America 

  • United States
  • Canada 


  • UK
  • Germany
  • Italy
  • Spain
  • France
  • Rest of Europe  


  • China
  • India
  • Japan
  • Rest of Asia-Pacific  

Rest of the World 

Company Profiles 

  • BioControl Medical Inc.
  • Boston Scientific Corp.
  • Cyberonics Inc.
  • Medtronic, Inc.
  • Neuronetics Inc. 
  • Neuropace Inc. 
  • Neurosigma Inc. 
  • Nevro Corp.
  • Nuvectra Corp.
  • St. Jude Medical Inc.
  • Synapse Biomedical Inc.  

About Orion Market Research 

OMR provide global and regional market reports of various domains such as healthcare, energy, IT, chemicals, and automobiles. OMR provide a 360-degree view of the market with parametric analysis, key market insights, key findings, statistical forecasts, competitive landscape, extensive segmentation, key trends, strategic recommendations and detailed company profiles. 

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari


Contact no: +1 646-755-7667, +91 7803040404

Like it? Share it!

OMR Global

About the Author

OMR Global
Joined: November 12th, 2019
Articles Posted: 203

More by this author